Literature DB >> 21904017

A new in vivo test method to compare wound dressing fluid handling characteristics and wear time.

James B Lutz1, Cindy L Zehrer, Staci E Solfest, Shelley-Ann Walters.   

Abstract

A refined in vivo artificial wound model utilizing artificial wound fluid (AWF) was developed to overcome important limitations such as adhesive-skin interactions, movement, pressure, shear, and varying environmental conditions in in vitro models. Using this model, a study with primary endpoints of wear time and fluid handling capacity was conducted to compare two foam dressings: a high performance (HPF) dressing and an adhesive dressing (AAF). A 10-cm(2) artificial wound bed, created using a nonstick absorbent pad, was applied to the lower back of 24 healthy volunteers and the tip of a 23-gauge catheter was inserted into the pad to administer AWF. The pad and catheter were secured in place with paper tape and covered with the test dressings. This model and 1.0-mL AWF infusions every 12 hours was used to simulate highly exudating wounds. The HPF dressing absorbed 75% more fluid before failure and remained intact for a median of 6.1 days compared to 3.5 days for the AAF dressing (P <0.001, Cox proportional hazard model). Comparisons between dressing outcomes using this model and previously published in vitro results suggest the model may be valid and reliable. Studies to ascertain the ability of this model to predict clinical dressing performance and research to compare other wound outcomes that affect dressing change frequency and cost (eg, healing) are needed.

Mesh:

Year:  2011        PMID: 21904017

Source DB:  PubMed          Journal:  Ostomy Wound Manage        ISSN: 0889-5899            Impact factor:   2.629


  3 in total

1.  A comparison of the in vitro moisture vapour transmission rate and in vivo fluid-handling capacity of six adhesive foam dressings to a newly reformulated adhesive foam dressing.

Authors:  Cindy L Zehrer; David Holm; Staci E Solfest; Shelley-Ann Walters
Journal:  Int Wound J       Date:  2013-01-30       Impact factor: 3.315

2.  Synergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37.

Authors:  Somayeh Sadeghi; Haleh Bakhshandeh; Reza Ahangari Cohan; Afshin Peirovi; Parastoo Ehsani; Dariush Norouzian
Journal:  Int J Nanomedicine       Date:  2019-12-10

3.  Moist Wound Healing with Commonly Available Dressings.

Authors:  Kristo Nuutila; Elof Eriksson
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-02-11       Impact factor: 4.730

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.